The first 1,000 days—from conception to a child’s second birthday—are a critical window for lifelong health and development. Yet critical questions in maternal and infant health often remain unanswered due to limited real-world data. Traditional lab-based studies are costly, slow, and fragmented, requiring extensive funding, protocol design, data collection, and analysis. This creates delays in clinical trials, pilot studies, and product development, leaving a gap between real-world experiences and research insights.
Questions like:
- Does magnesium supplementation reduce pregnancy migraines?
- How does breastfeeding duration impact infant weight gain?
- Which nutrients are pregnant women actively seeking?
- Which symptoms influence supplement use during pregnancy?
are difficult to answer with current approaches.
Amomi closes this gap. We transform real-world experiences from families into structured, anonymized insights, following CDISC standards to ensure research-ready quality. Our secure infrastructure stores user data anonymously on AWS, with SOC 2 and SOC 3 compliance.
Familiar with clinical trial frameworks, Amomi makes it easier for drug and healthcare companies to leverage real-world maternal and early-life data to accelerate research, support product development, and streamline regulatory approval processes. By connecting insights across pre-pregnancy, pregnancy, and early childhood, Amomi empowers organizations to make faster, more informed decisions—supporting healthier outcomes during the most critical window of life.opment, and healthcare decisions.
Maternal & Early Life Intelligence Platform 